These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9542692)

  • 21. Optimizing the therapeutic approach of transurethral alprostadil.
    Ekman P; Sjögren L; Englund G; Persson BE
    BJU Int; 2000 Jul; 86(1):68-74. PubMed ID: 10886086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of transurethral alprostadil therapy in men with erectile dysfunction. MUSE Study Group.
    Williams G; Abbou CC; Amar ET; Desvaux P; Flam TA; Lycklama à Nijeholt GA; Lynch SF; Morgan RJ; Müller SC; Porst H; Pryor JP; Ryan P; Witzsch UK; Hall MM; Place VA; Spivack AP; Gesundheit N
    Br J Urol; 1998 Jun; 81(6):889-94. PubMed ID: 9666777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination therapy: medicated urethral system for erection enhances sexual satisfaction in sildenafil citrate failure following nerve-sparing radical prostatectomy.
    Raina R; Nandipati KC; Agarwal A; Mansour D; Kaelber DC; Zippe CD
    J Androl; 2005; 26(6):757-60. PubMed ID: 16291971
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intraurethral alprostadil for erectile dysfunction: a review of the literature.
    Costa P; Potempa AJ
    Drugs; 2012 Dec; 72(17):2243-54. PubMed ID: 23170913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rationale for combination therapy of intraurethral prostaglandin E(1) and sildenafil in the salvage of erectile dysfunction patients desiring noninvasive therapy.
    Nehra A; Blute ML; Barrett DM; Moreland RB
    Int J Impot Res; 2002 Feb; 14 Suppl 1():S38-42. PubMed ID: 11850734
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intraurethral application of alprostadil in patients with failed inflatable penile prosthesis.
    Benevides MD; Carson CC
    J Urol; 2000 Mar; 163(3):785-7. PubMed ID: 10687977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of colour duplex ultrasonography after transurethral alprostadil and intracavernous alprostadil in the assessment of erectile dysfunction.
    Ahn HS; Lee SW; Yoon SJ; Hann HJ; Hong JM
    J Int Med Res; 2004; 32(3):317-23. PubMed ID: 15174226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Evaluation of a nurse educational program for intracavernous alprostadil injections after radical prostatectomy].
    Yiou R; Khodari M; Lingombet O; Rudy M; Mine V; de la Taille A; Salomon L; Abbou C
    Prog Urol; 2011 Apr; 21(4):283-7. PubMed ID: 21482404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Can self-injection therapy cure impotence?
    Sharlip ID
    Adv Exp Med Biol; 1997; 433():83-6. PubMed ID: 9561109
    [No Abstract]   [Full Text] [Related]  

  • 30. A double-blind, placebo-controlled evaluation of the erectile response to transurethral alprostadil.
    Hellstrom WJ; Bennett AH; Gesundheit N; Kaiser FE; Lue TF; Padma-Nathan H; Peterson CA; Tam PY; Todd LK; Varady JC; Place VA
    Urology; 1996 Dec; 48(6):851-6. PubMed ID: 8973666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The therapeutic and diagnostic potentials of the intra-corpora cavernosa use of alprostadil, Edex, in patients with erectile dysfunction].
    Mzo EB; Dmitriev DG
    Ter Arkh; 1995; 67(10):45-8. PubMed ID: 8779105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Re: Recovery of spontaneous erectile function after nerve-sparing radical retropubic prostatectomy with and without early intracavernous injections of alprostadil: results of a prospective, randomized trial.
    Scholz M; Strum S
    J Urol; 1999 Jun; 161(6):1914-5. PubMed ID: 10332471
    [No Abstract]   [Full Text] [Related]  

  • 33. Does alprostadil cream hit the spot?
    Drug Ther Bull; 2015 Feb; 53(2):21-4. PubMed ID: 25678352
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intracavernous injection of prostaglandin E1 in spinal cord injured patients with erectile dysfunction. A preliminary report.
    Tang SF; Chu NK; Wong MK
    Paraplegia; 1995 Dec; 33(12):731-3. PubMed ID: 8927414
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term efficacy and compliance of MUSE for erectile dysfunction following radical prostatectomy: SHIM (IIEF-5) analysis.
    Raina R; Agarwal A; Zaramo CE; Ausmundson S; Mansour D; Zippe CD
    Int J Impot Res; 2005; 17(1):86-90. PubMed ID: 15526008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of transurethal alprostadil for safety and efficacy in men with erectile dysfunction.
    Kongkanand A; Ratana-Olarn K; Wuddhikarn S; Luengwattanakit S; Tantiwong A; Ruengdilokrat S; Opanuraks J; Sripalakit S
    J Med Assoc Thai; 2002 Feb; 85(2):223-8. PubMed ID: 12081123
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Current role of intracavernous therapy in the treatment of erectile dysfunction].
    Asuar Aydillo S
    Arch Esp Urol; 2002 Jun; 55(5):475-82. PubMed ID: 12174413
    [No Abstract]   [Full Text] [Related]  

  • 38. Re: Disappointing initial results with transurethral alprostadil for erectile dysfunction in a urology practice setting.
    Subramonian K; Weston PM
    J Urol; 1999 Jul; 162(1):168-9. PubMed ID: 10379774
    [No Abstract]   [Full Text] [Related]  

  • 39. Re: Disappointing initial results with transurethral alprostadil for erectile dysfunction in a urology practice setting.
    Hellstrom WJ; Lewis RW
    J Urol; 1999 Oct; 162(4):1390. PubMed ID: 10492215
    [No Abstract]   [Full Text] [Related]  

  • 40. Prospective comparative study with intracavernous sodium nitroprusside and prostaglandin E1 in patients with erectile dysfunction.
    Martínez-Piñeiro L; Cortés R; Cuervo E; López-Tello J; Cisneros J; Martínez-Piñeiro JA
    Eur Urol; 1998 Oct; 34(4):350-4. PubMed ID: 9748684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.